|
ENY2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.23772128499422E-13 |
| Normal-vs-Stage3 |
1.88737914186277E-15 |
| Normal-vs-Stage4 |
1.62492241884138E-12 |
| Stage1-vs-Stage2 |
3.184400E-01 |
| Stage1-vs-Stage3 |
3.188800E-01 |
| Stage1-vs-Stage4 |
1.217020E-03 |
| Stage2-vs-Stage3 |
8.388800E-01 |
| Stage2-vs-Stage4 |
8.568100E-02 |
| Stage3-vs-Stage4 |
3.685800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.76180009154359E-10 |
| Normal-vs-Asian |
6.42264019745653E-12 |
| Caucasian-vs-AfricanAmerican |
5.939400E-01 |
| Caucasian-vs-Asian |
9.384600E-01 |
| AfricanAmerican-vs-Asian |
5.623400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.841900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62536650805123E-12 |
| Normal-vs-Age(81-100Yrs) |
2.468100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.761590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.635700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.104200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.091800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.373900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.983500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.563200E-01 |
| Classical-VS-Follicular |
9.760000E-01 |
| Classical-VS-Other |
5.846000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
5.958200E-01 |
| Tall-VS-Other |
8.917400E-01 |
| Tall-VS-Normal |
1.13639986309977E-10 |
| Follicular-VS-Other |
6.860400E-01 |
| Follicular-VS-Normal |
5.38724620469111E-12 |
| Other-VS-Normal |
9.71309999999725E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.5342949960816E-11 |
| N0-vs-N1 |
6.929400E-01 |
|
|
